# Xiangyang Zhang

> Xiangyang Zhang is a Series B investor at Haitong Capital backing Health Care and Biotechnology. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Haitong Capital](https://shizune.co/investors/profile/haitong-capital)
- Location: Shanghai, China
- Total investments: 3
- Last investment: Feb 2025
- Lead investor: 33%
- Last updated: Aug 2026

Xiangyang Zhang is a Series B investor at Haitong Capital in Shanghai focused on Health Care and Biotechnology. Xiangyang Zhang - Chairman @ Haitong Capital

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 67% |
| Biotechnology | 2 | 67% |
| Pharmaceutical | 2 | 67% |
| Biopharma | 1 | 33% |
| Clinical Trials | 1 | 33% |

8 industries tracked in total.

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Tejin Intelligence | Tejin Intelligence is deeply involved in radio sensing and spectrum big data analysis technology, and is dedicated to providing the world's leading low-altitude safety management and control solutions, assisting in the development of new ground-air integrated three-dimensional security infrastructure for smart cities, and striving for refinedmanagement of urban low-altitude airspace. |  | Series B | Feb 24, 2025 |  |
| Healsun Biopharm | Healsun Biopharm is a pharmaceutical company development processes such as molecular construction, stable cell line screening, cell culture process development, protein purification and process development, antibody-coupled drug process development and bioanalytical method development. | $36.8M | Series B | Aug 18, 2022 |  |
| Gensciences | Gensciences develops drugs that focus on underserved illnesses like hemophilia, metabolic diseases, and anti-tumor fields. | $123.6M | Series B | Mar 04, 2021 |  |

3 of 3 investments shown.

## Co-investors
- [CDH Investments](https://shizune.co/investors/profile/cdh-investments) — VC Fund, 2 deals together
- [Conswall Capital](https://shizune.co/investors/profile/conswall-capital) — VC Fund, 1 deal together
- [Dongfang Jiafu](https://shizune.co/investors/profile/dongfang-jiafu) — VC Fund, 1 deal together
- [EFung Capital](https://shizune.co/investors/profile/efung-capital) — VC Fund, 1 deal together
- [Haibang Capital](https://shizune.co/investors/profile/haibang-capital) — VC Fund, 1 deal together
- [Haitong Kaiyuan Investment](https://shizune.co/investors/profile/haitong-kaiyuan-investment) — VC Fund, 1 deal together

## About Haitong Capital

VC Fund · Lisbon, Portugal

Haitong Capital is a private investment firm focuses on growing small and medium-sized companies. It is a wholly-owned subsidiary of Haitong Securities and an investment management platform for private equity investment business. Haitong Capital focuses on and tracks growing small and medium-sized companies with good integrity records, maturebusiness models and unique core competencies.

2 contacts available at Haitong Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Wu Min | CEO | https://shizune.co/investors/profile/wu-min |
| Xiangyang Zhang | Chairman | https://shizune.co/investors/profile/xiangyang-zhang |

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Xiangyang Zhang invest in?

Xiangyang Zhang invests primarily in Health Care, Biotechnology and Pharmaceutical startups, most often at Series B stage. Most of the 3 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Xiangyang Zhang last invest?

The most recent investment recorded for Xiangyang Zhang closed in Feb 2025. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co